ID   GCST_HUMAN              Reviewed;         403 AA.
AC   P48728; A8K3I5; B4DE61; B4DJQ0; E9PBG1; Q96IG6;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=Aminomethyltransferase, mitochondrial {ECO:0000305};
DE            EC=2.1.2.10 {ECO:0000269|PubMed:16051266};
DE   AltName: Full=Glycine cleavage system T protein {ECO:0000303|PubMed:7916605};
DE            Short=GCVT;
DE   Flags: Precursor;
GN   Name=AMT {ECO:0000312|HGNC:HGNC:473}; Synonyms=GCST;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7916605; DOI=10.1006/bbrc.1993.1480;
RA   Hayasaka K., Nanao K., Takada G., Okamura-Ikeda K., Motokawa Y.;
RT   "Isolation and sequence determination of cDNA encoding human T-protein
RT   of the glycine cleavage system.";
RL   Biochem. Biophys. Res. Commun. 192:766-771(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8188235; DOI=10.1006/geno.1994.1007;
RA   Nanao K., Takada G., Takahashi E., Seki N., Komatsu Y.,
RA   Okamura-Ikeda K., Motokawa Y., Hayasaka K.;
RT   "Structure and chromosomal localization of the aminomethyltransferase
RT   gene (AMT).";
RL   Genomics 19:27-30(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Cerebellum, Heart, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4-386 (ISOFORM 4).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 29-403 ALONE AND IN COMPLEX
RP   WITH 5-METHYLTETRAHYDROFOLATE, SUBSTRATE-BINDING SITES, CATALYTIC
RP   ACTIVITY, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, CHARACTERIZATION OF
RP   VARIANTS NKH ILE-145; ASP-269 AND HIS-320, AND MUTAGENESIS OF ASP-129.
RX   PubMed=16051266; DOI=10.1016/j.jmb.2005.06.056;
RA   Okamura-Ikeda K., Hosaka H., Yoshimura M., Yamashita E., Toma S.,
RA   Nakagawa A., Fujiwara K., Motokawa Y., Taniguchi H.;
RT   "Crystal structure of human T-protein of glycine cleavage system at
RT   2.0 A resolution and its implication for understanding non-ketotic
RT   hyperglycinemia.";
RL   J. Mol. Biol. 351:1146-1159(2005).
RN   [9]
RP   VARIANTS NKH ARG-47; ASP-269 AND HIS-320, AND INVOLVEMENT IN NKH.
RX   PubMed=8005589; DOI=10.1007/BF00201565;
RA   Nanao K., Okamura-Ikeda K., Motokawa Y., Danks D.M., Baumgartner E.R.,
RA   Takada G., Hayasaka K.;
RT   "Identification of the mutations in the T-protein gene causing typical
RT   and atypical nonketotic hyperglycinemia.";
RL   Hum. Genet. 93:655-658(1994).
RN   [10]
RP   VARIANT NKH ARG-42.
RX   PubMed=9600239; DOI=10.1007/s004390050716;
RA   Kure S., Mandel H., Rolland M.-O., Sakata Y., Shinka T., Drugan A.,
RA   Boneh A., Tada K., Matsubara Y., Narisawa K.;
RT   "A missense mutation (His42Arg) in the T-protein gene from a large
RT   Israeli-Arab kindred with nonketotic hyperglycinemia.";
RL   Hum. Genet. 102:430-434(1998).
RN   [11]
RP   VARIANT NKH HIS-276.
RX   PubMed=9621520; DOI=10.1007/s100380050055;
RA   Kure S., Shinka T., Sakata Y., Osamu N., Takayanagi M., Tada K.,
RA   Matsubara Y., Narisawa K.;
RT   "A one-base deletion (183delC) and a missense mutation (D276H) in the
RT   T-protein gene from a Japanese family with nonketotic
RT   hyperglycinemia.";
RL   J. Hum. Genet. 43:135-137(1998).
RN   [12]
RP   VARIANTS NKH LYS-211 AND HIS-320.
RX   PubMed=10873393; DOI=10.1006/mgme.2000.3000;
RA   Toone J.R., Applegarth D.A., Coulter-Mackie M.B., James E.R.;
RT   "Biochemical and molecular investigations of patients with nonketotic
RT   hyperglycinemia.";
RL   Mol. Genet. Metab. 70:116-121(2000).
RN   [13]
RP   VARIANTS NKH ILE-145 AND HIS-320.
RX   PubMed=11286506; DOI=10.1006/mgme.2001.3158;
RA   Toone J.R., Applegarth D.A., Coulter-Mackie M.B., James E.R.;
RT   "Recurrent mutations in P- and T-proteins of the glycine cleavage
RT   complex and a novel T-protein mutation (N145I): a strategy for the
RT   molecular investigation of patients with nonketotic hyperglycinemia
RT   (NKH).";
RL   Mol. Genet. Metab. 72:322-325(2001).
RN   [14]
RP   VARIANT NKH CYS-265.
RX   PubMed=26371980; DOI=10.1016/j.ejpn.2015.08.008;
RA   Belcastro V., Barbarini M., Barca S., Mauro I.;
RT   "A novel AMT gene mutation in a newborn with nonketotic
RT   hyperglycinemia and early myoclonic encephalopathy.";
RL   Eur. J. Paediatr. Neurol. 20:192-195(2016).
CC   -!- FUNCTION: The glycine cleavage system catalyzes the degradation of
CC       glycine. {ECO:0000269|PubMed:16051266}.
CC   -!- CATALYTIC ACTIVITY: [Protein]-S(8)-aminomethyldihydrolipoyllysine
CC       + tetrahydrofolate = [protein]-dihydrolipoyllysine + 5,10-
CC       methylenetetrahydrofolate + NH(3). {ECO:0000269|PubMed:16051266}.
CC   -!- SUBUNIT: The glycine cleavage system is composed of four proteins:
CC       P, T, L and H. {ECO:0000305|PubMed:16051266}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305|PubMed:16051266}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P48728-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P48728-2; Sequence=VSP_042557;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P48728-3; Sequence=VSP_043288;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P48728-4; Sequence=VSP_045418;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Non-ketotic hyperglycinemia (NKH) [MIM:605899]: Autosomal
CC       recessive disease characterized by accumulation of a large amount
CC       of glycine in body fluid and by severe neurological symptoms.
CC       {ECO:0000269|PubMed:10873393, ECO:0000269|PubMed:11286506,
CC       ECO:0000269|PubMed:16051266, ECO:0000269|PubMed:26371980,
CC       ECO:0000269|PubMed:8005589, ECO:0000269|PubMed:9600239,
CC       ECO:0000269|PubMed:9621520}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the GcvT family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D13811; BAA02967.1; -; mRNA.
DR   EMBL; D14686; BAA03512.1; -; Genomic_DNA.
DR   EMBL; AK290600; BAF83289.1; -; mRNA.
DR   EMBL; AK293481; BAG56972.1; -; mRNA.
DR   EMBL; AK296177; BAG58912.1; -; mRNA.
DR   EMBL; AC104452; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64984.1; -; Genomic_DNA.
DR   EMBL; BC007546; AAH07546.2; -; mRNA.
DR   CCDS; CCDS2797.1; -. [P48728-1]
DR   CCDS; CCDS54583.1; -. [P48728-2]
DR   CCDS; CCDS54584.1; -. [P48728-3]
DR   CCDS; CCDS54585.1; -. [P48728-4]
DR   PIR; I54192; I54192.
DR   RefSeq; NP_000472.2; NM_000481.3. [P48728-1]
DR   RefSeq; NP_001158182.1; NM_001164710.1. [P48728-3]
DR   RefSeq; NP_001158183.1; NM_001164711.1. [P48728-2]
DR   RefSeq; NP_001158184.1; NM_001164712.1. [P48728-4]
DR   UniGene; Hs.102; -.
DR   PDB; 1WSR; X-ray; 2.00 A; A/B=29-403.
DR   PDB; 1WSV; X-ray; 2.60 A; A/B=29-403.
DR   PDBsum; 1WSR; -.
DR   PDBsum; 1WSV; -.
DR   ProteinModelPortal; P48728; -.
DR   SMR; P48728; -.
DR   BioGrid; 106772; 2.
DR   IntAct; P48728; 1.
DR   STRING; 9606.ENSP00000273588; -.
DR   DrugBank; DB04789; 5-methyltetrahydrofolic acid.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB00116; Tetrahydrofolic acid.
DR   iPTMnet; P48728; -.
DR   PhosphoSitePlus; P48728; -.
DR   BioMuta; AMT; -.
DR   DMDM; 1346122; -.
DR   EPD; P48728; -.
DR   MaxQB; P48728; -.
DR   PaxDb; P48728; -.
DR   PeptideAtlas; P48728; -.
DR   PRIDE; P48728; -.
DR   Ensembl; ENST00000273588; ENSP00000273588; ENSG00000145020. [P48728-1]
DR   Ensembl; ENST00000395338; ENSP00000378747; ENSG00000145020. [P48728-4]
DR   Ensembl; ENST00000458307; ENSP00000415619; ENSG00000145020. [P48728-3]
DR   Ensembl; ENST00000636522; ENSP00000489758; ENSG00000145020. [P48728-2]
DR   GeneID; 275; -.
DR   KEGG; hsa:275; -.
DR   UCSC; uc003cww.4; human. [P48728-1]
DR   CTD; 275; -.
DR   DisGeNET; 275; -.
DR   GeneCards; AMT; -.
DR   GeneReviews; AMT; -.
DR   HGNC; HGNC:473; AMT.
DR   HPA; HPA005566; -.
DR   MalaCards; AMT; -.
DR   MIM; 238310; gene.
DR   MIM; 605899; phenotype.
DR   neXtProt; NX_P48728; -.
DR   OpenTargets; ENSG00000145020; -.
DR   Orphanet; 289863; Atypical glycine encephalopathy.
DR   Orphanet; 289860; Infantile glycine encephalopathy.
DR   Orphanet; 289857; Neonatal glycine encephalopathy.
DR   PharmGKB; PA24780; -.
DR   eggNOG; KOG2770; Eukaryota.
DR   eggNOG; COG0404; LUCA.
DR   GeneTree; ENSGT00530000063120; -.
DR   HOGENOM; HOG000239380; -.
DR   HOVERGEN; HBG005822; -.
DR   InParanoid; P48728; -.
DR   KO; K00605; -.
DR   OMA; HSPILNM; -.
DR   OrthoDB; EOG091G07Z1; -.
DR   PhylomeDB; P48728; -.
DR   TreeFam; TF313026; -.
DR   BioCyc; MetaCyc:HS07223-MONOMER; -.
DR   BRENDA; 2.1.2.10; 2681.
DR   Reactome; R-HSA-6783984; Glycine degradation.
DR   SABIO-RK; P48728; -.
DR   ChiTaRS; AMT; human.
DR   EvolutionaryTrace; P48728; -.
DR   GenomeRNAi; 275; -.
DR   PRO; PR:P48728; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000145020; -.
DR   CleanEx; HS_AMT; -.
DR   ExpressionAtlas; P48728; baseline and differential.
DR   Genevisible; P48728; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004047; F:aminomethyltransferase activity; IMP:UniProtKB.
DR   GO; GO:0008483; F:transaminase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006546; P:glycine catabolic process; TAS:ProtInc.
DR   GO; GO:0019464; P:glycine decarboxylation via glycine cleavage system; IMP:UniProtKB.
DR   GO; GO:0046487; P:glyoxylate metabolic process; TAS:Reactome.
DR   Gene3D; 2.40.30.110; -; 1.
DR   InterPro; IPR006223; GCS_T.
DR   InterPro; IPR028896; GCST/DmdA.
DR   InterPro; IPR013977; GCV_T_C.
DR   InterPro; IPR006222; GCV_T_N.
DR   InterPro; IPR029043; GcvT/YgfZ_C.
DR   Pfam; PF01571; GCV_T; 1.
DR   Pfam; PF08669; GCV_T_C; 1.
DR   PIRSF; PIRSF006487; GcvT; 1.
DR   SUPFAM; SSF101790; SSF101790; 1.
DR   TIGRFAMs; TIGR00528; gcvT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Aminotransferase;
KW   Complete proteome; Disease mutation; Mitochondrion;
KW   Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1     28       Mitochondrion.
FT                                {ECO:0000250|UniProtKB:P25285}.
FT   CHAIN        29    403       Aminomethyltransferase, mitochondrial.
FT                                /FTId=PRO_0000010755.
FT   BINDING     232    232       Substrate. {ECO:0000269|PubMed:16051266}.
FT   BINDING     261    261       Substrate. {ECO:0000269|PubMed:16051266}.
FT   BINDING     399    399       Substrate. {ECO:0000269|PubMed:16051266}.
FT   VAR_SEQ      30     85       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042557.
FT   VAR_SEQ     113    156       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043288.
FT   VAR_SEQ     380    403       VRRKQQMAVVSKMPFVPTNYYTLK -> LPSGPCF (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045418.
FT   VARIANT      42     42       H -> R (in NKH; dbSNP:rs121964983).
FT                                {ECO:0000269|PubMed:9600239}.
FT                                /FTId=VAR_007951.
FT   VARIANT      47     47       G -> R (in NKH; dbSNP:rs121964982).
FT                                {ECO:0000269|PubMed:8005589}.
FT                                /FTId=VAR_007952.
FT   VARIANT     145    145       N -> I (in NKH; loss of
FT                                aminomethyltransferase activity;
FT                                dbSNP:rs386833682).
FT                                {ECO:0000269|PubMed:11286506,
FT                                ECO:0000269|PubMed:16051266}.
FT                                /FTId=VAR_016847.
FT   VARIANT     211    211       E -> K (in NKH; dbSNP:rs116192290).
FT                                {ECO:0000269|PubMed:10873393}.
FT                                /FTId=VAR_016848.
FT   VARIANT     265    265       R -> C (in NKH; dbSNP:rs779483959).
FT                                {ECO:0000269|PubMed:26371980}.
FT                                /FTId=VAR_074107.
FT   VARIANT     269    269       G -> D (in NKH; decreased
FT                                aminomethyltransferase activity;
FT                                dbSNP:rs121964981).
FT                                {ECO:0000269|PubMed:16051266,
FT                                ECO:0000269|PubMed:8005589}.
FT                                /FTId=VAR_007953.
FT   VARIANT     276    276       D -> H (in NKH; dbSNP:rs121964984).
FT                                {ECO:0000269|PubMed:9621520}.
FT                                /FTId=VAR_007954.
FT   VARIANT     320    320       R -> H (in NKH; loss of
FT                                aminomethyltransferase activity;
FT                                dbSNP:rs121964985).
FT                                {ECO:0000269|PubMed:10873393,
FT                                ECO:0000269|PubMed:11286506,
FT                                ECO:0000269|PubMed:16051266,
FT                                ECO:0000269|PubMed:8005589}.
FT                                /FTId=VAR_007955.
FT   MUTAGEN     129    129       D->A,N: Loss of aminomethyltransferase
FT                                activity. {ECO:0000269|PubMed:16051266}.
FT   CONFLICT     95     95       V -> C (in Ref. 2; BAA03512).
FT                                {ECO:0000305}.
FT   HELIX        39     44       {ECO:0000244|PDB:1WSR}.
FT   STRAND       48     52       {ECO:0000244|PDB:1WSR}.
FT   STRAND       55     60       {ECO:0000244|PDB:1WSR}.
FT   HELIX        65     74       {ECO:0000244|PDB:1WSR}.
FT   STRAND       75     80       {ECO:0000244|PDB:1WSR}.
FT   STRAND       84     91       {ECO:0000244|PDB:1WSR}.
FT   HELIX        94    101       {ECO:0000244|PDB:1WSR}.
FT   STRAND      102    104       {ECO:0000244|PDB:1WSR}.
FT   STRAND      113    120       {ECO:0000244|PDB:1WSR}.
FT   STRAND      126    134       {ECO:0000244|PDB:1WSR}.
FT   STRAND      138    144       {ECO:0000244|PDB:1WSR}.
FT   HELIX       146    148       {ECO:0000244|PDB:1WSR}.
FT   HELIX       149    165       {ECO:0000244|PDB:1WSR}.
FT   STRAND      171    174       {ECO:0000244|PDB:1WSR}.
FT   STRAND      178    184       {ECO:0000244|PDB:1WSR}.
FT   HELIX       187    192       {ECO:0000244|PDB:1WSR}.
FT   HELIX       199    201       {ECO:0000244|PDB:1WSR}.
FT   STRAND      206    212       {ECO:0000244|PDB:1WSR}.
FT   STRAND      215    222       {ECO:0000244|PDB:1WSR}.
FT   STRAND      225    235       {ECO:0000244|PDB:1WSR}.
FT   HELIX       237    248       {ECO:0000244|PDB:1WSR}.
FT   STRAND      253    255       {ECO:0000244|PDB:1WSR}.
FT   HELIX       258    267       {ECO:0000244|PDB:1WSR}.
FT   TURN        273    275       {ECO:0000244|PDB:1WSR}.
FT   TURN        283    287       {ECO:0000244|PDB:1WSR}.
FT   HELIX       289    291       {ECO:0000244|PDB:1WSR}.
FT   HELIX       294    299       {ECO:0000244|PDB:1WSR}.
FT   HELIX       305    312       {ECO:0000244|PDB:1WSR}.
FT   STRAND      319    328       {ECO:0000244|PDB:1WSR}.
FT   STRAND      335    337       {ECO:0000244|PDB:1WSR}.
FT   STRAND      343    353       {ECO:0000244|PDB:1WSR}.
FT   TURN        354    357       {ECO:0000244|PDB:1WSR}.
FT   STRAND      358    365       {ECO:0000244|PDB:1WSR}.
FT   HELIX       367    369       {ECO:0000244|PDB:1WSR}.
FT   STRAND      375    380       {ECO:0000244|PDB:1WSR}.
FT   STRAND      383    390       {ECO:0000244|PDB:1WSR}.
SQ   SEQUENCE   403 AA;  43946 MW;  218DC9EEADFA9102 CRC64;
     MQRAVSVVAR LGFRLQAFPP ALCRPLSCAQ EVLRRTPLYD FHLAHGGKMV AFAGWSLPVQ
     YRDSHTDSHL HTRQHCSLFD VSHMLQTKIL GSDRVKLMES LVVGDIAELR PNQGTLSLFT
     NEAGGILDDL IVTNTSEGHL YVVSNAGCWE KDLALMQDKV RELQNQGRDV GLEVLDNALL
     ALQGPTAAQV LQAGVADDLR KLPFMTSAVM EVFGVSGCRV TRCGYTGEDG VEISVPVAGA
     VHLATAILKN PEVKLAGLAA RDSLRLEAGL CLYGNDIDEH TTPVEGSLSW TLGKRRRAAM
     DFPGAKVIVP QLKGRVQRRR VGLMCEGAPM RAHSPILNME GTKIGTVTSG CPSPSLKKNV
     AMGYVPCEYS RPGTMLLVEV RRKQQMAVVS KMPFVPTNYY TLK
//
